Hormonal contraception and risk of breast cancer: a critical look

被引：4

作者：

Barriga, Patricio ^{[1
]}

Vanhauwaert, Paula ^{[2
]}

Porcile, Arnaldo ^{[3
]}

机构：

[1] Finis Terrae Univ, Sch Med, Santiago, Chile

[2] Clin Alemana Santiago, Santiago, Chile

[3] Univ Chile, Fac Med, Santiago, Chile

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 2019年 / 35卷 / 06期

关键词：

Hormonal contraception; breast cancer; breast cancer risk; ORAL-CONTRACEPTIVES; HEALTH; THERAPY;

D O I：

10.1080/09513590.2019.1576610

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Today health professionals are not only required to know medicine, but scientific reading, interpretation, and communication of new data. The new information about contraception and hormonal therapies must be analyzed by gynecologists to determine whether or not the new data are applicable to their patients and if it has an impact on their health. Recently a new study of hormonal contraceptives and the risk of breast cancer was published. In this study, the investigators found an elevation of the relative risk of breast cancers on the users versus the nonusers of hormonal contraception. After analyzing the publication and other data available, it is our opinion that it is a very low increase of the risk and its impact should be evaluated case by case, not forgetting to take into account the numerous beneficial effects that hormonal contraception have.

引用

页码：460 / 462

页数：3

共 24 条

[1] Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks [J].